Wellington Management Group
INFI

Wellington Management Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Wellington Management Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,518,465
Closed -$1.56M – 2155
2019
Q3 		$1.56M Sell
1,518,465
-39,095
-3% -$53.3K ﹤0.01% 1643
2019
Q2 		$2.8M Hold
1,557,560
– – ﹤0.01% 1535
2019
Q1 		$2.93M Hold
1,557,560
– – ﹤0.01% 1521
2018
Q4 		$1.84M Hold
1,557,560
– – ﹤0.01% 1660
2018
Q3 		$4.22M Sell
1,557,560
-40,749
-3% -$84.3K ﹤0.01% 1522
2018
Q2 		$3.05M Buy
1,598,309
+88,000
+6% +$178K ﹤0.01% 1620
2018
Q1 		$3.17M Buy
1,510,309
+913,279
+153% +$1.96M ﹤0.01% 1613
2017
Q4 		$1.21M Sell
597,030
-4,418,686
-88% -$9.17M ﹤0.01% 1855
2017
Q3 		$6.67M Buy
5,015,716
+301,609
+6% +$375K ﹤0.01% 1392
2017
Q2 		$7.4M Buy
4,714,107
+148,160
+3% +$286K ﹤0.01% 1305
2017
Q1 		$14.7M Buy
4,565,947
+207,876
+5% +$511K ﹤0.01% 1127
2016
Q4 		$5.88M Buy
4,358,071
+13,490
+0.3% +$17.6K ﹤0.01% 1354
2016
Q3 		$6.78M Buy
4,344,581
+1,581,152
+57% +$2.43M ﹤0.01% 1295
2016
Q2 		$3.68M Buy
2,763,429
+5,767
+0.2% +$27K ﹤0.01% 1445
2016
Q1 		$14.5M Buy
2,757,662
+622,340
+29% +$3.81M ﹤0.01% 1026
2015
Q4 		$16.8M Sell
2,135,322
-288,454
-12% -$2.48M ﹤0.01% 1019
2015
Q3 		$20.5M Buy
2,423,776
+399,252
+20% +$3.68M 0.01% 954
2015
Q2 		$22.2M Buy
2,024,524
+32,171
+2% +$413K 0.01% 985
2015
Q1 		$27.9M Buy
1,992,353
+137,858
+7% +$2.11M 0.01% 927
2014
Q4 		$31.3M Buy
1,854,495
+91,484
+5% +$1.33M 0.01% 886
2014
Q3 		$23.7M Sell
1,763,011
-24,765
-1% -$295K 0.01% 963
2014
Q2 		$22.8M Buy
1,787,776
+209,626
+13% +$2.18M 0.01% 995
2014
Q1 		$18.8M Sell
1,578,150
-385,850
-20% -$5.18M 0.01% 1051
2013
Q4 		$27.1M Buy
1,964,000
+263,451
+15% +$3.72M 0.01% 910
2013
Q3 		$29.7M Sell
1,700,549
-305,441
-15% -$5.85M 0.01% 865
2013
Q2 		$32.6M Buy
+2,005,990
New +$62.1M 0.01% 817

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wellington Management Group's INFI Position: Q4 2019 in Review

Wellington Management Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2019, closing a stake of 1,518,465 shares — an estimated $1.56M sold.

Wellington Management Group first reported a position in INFI in Q2 2013 and held it in 26 quarters. The position peaked at $32.6M in Q2 2013. 47 funds tracked by Wall St. Rank hold INFI as of Q4 2019.

  • Wellington Management Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • Wellington Management Group sold 1,518,465 Infinity Pharmaceuticals, Inc. shares in Q4 2019, an estimated $1.56M.
  • Wellington Management Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
  • Wellington Management Group's Infinity Pharmaceuticals, Inc. position peaked at $32.6M in Q2 2013.
  • 47 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2019.

Based on Wellington Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.